4//SEC Filing
Krempa David 4
Accession 0001437749-25-037745
CIK 0001710340other
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 4:56 PM ET
Size
7.5 KB
Accession
0001437749-25-037745
Insider Transaction Report
Form 4
Krempa David
Chief Business Officer
Transactions
- Tax Payment
Common Stock
2025-12-12$17.00/sh−6,264$106,488→ 632,180 total - Award
Restricted Stock Units
2025-12-11+5,300→ 638,468 total→ Common Stock (5,300 underlying)
Footnotes (5)
- [F1]Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of restricted stock units.
- [F2]The shares were sold in multiple trades at prices ranging from $16.83 to $17.11. The price reported above reflects the weighted average sales price.
- [F3]The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- [F4]Each restricted stock unit represents a contingent right to receive one share of ETON Common Stock.
- [F5]The restricted stock units vest immediately as of the award date.
Documents
Issuer
Eton Pharmaceuticals, Inc.
CIK 0001710340
Entity typeother
Related Parties
1- filerCIK 0001968254
Filing Metadata
- Form type
- 4
- Filed
- Dec 11, 7:00 PM ET
- Accepted
- Dec 12, 4:56 PM ET
- Size
- 7.5 KB